The Partners Clinical Research Centre

We are “modeled” after US Research Sites and our team consists of US Board Certified trained Investigators and experienced research staff. We have been successful in conducting Phase IB through Phase IV Clinical Trials and with our recent merger we have substantially increased our scope with the ability to conduct a multitude of varied medically indicated Clinical Trials. We have conducted both investigative new drug as well as investigative medical device trials. Our trials have been secured through large Pharmaceutical Companies, and small biotech firms, and CROs from the United States Canada and South American Regions. Our state of the art facility has been designed specifically for the conduction of Clinical Trials. Our location affords close proximity to local hospitals one of which is JCAHO accredited. We are also conveniently located near the new recently expanded Sir Lynden Pindling International Airport. This new airport (one of the very few worldwide) is equipped with US Immigration and Customs Clearance facilities which provide expedited business travel. The airport accommodates frequent flights from various International regions and numerous cities in the United States. Our monitors find it convenient to travel for visits often times for one day with no need to exchange currency. Our demographics include a population of over 375,000. The ethnicity is 85 % African descent, 3% Asian and Hispanic and 12% Caucasian, with a high literacy rate. The majority of the Bahamian population resides in the Capital City, Nassau on the Island of New Providence. The island is 22 miles long by 7 miles wide, thereby creating a dense patient population base which provides ease of access for our trial participants. If you need to treat neuropathic pain from different conditions read GoodmenProject reviews.

We are fortunate to have established a satisfied subject base and thus have enjoyed favorable community attitudes toward our research trials, with patients that also have Medicare or Medicaid, and for older citizens Medicaid currently offers incontinence supplies coverage in 45 states and more. Additionally, we have proven high compliance rates with our enrolled subjects and optimal subject retention. Our new facility is equipped with a full laboratory, compliant with CDC guidelines, full operating pharmacy, multiple full time Investigators, In-house Comprehensive Imaging Centre with CT capabilities, Nuclear Medicine, Heart Centre with echocardiography and complete cardiac testing, Cancer Centre accredited by the American College Radiation Oncology (ACRO), Chemo suites and Comprehensive Dialysis Centre.

Our vast experience locally affords us the ability to achieve fast turnaround times from feasibility to study start up through the successful completion of the trial. Our regulatory environment is streamlined in which we utilize both a Local Ethics Committee and a Central IRB for dual oversight. We are proficient in FDA regulations, maintain strict adherence to GCPs, ICH guidelines, and are compliant with the relative local laws. We have established site specific SOPs which are reviewed and updated on a frequent basis.

Our Investigators are US board certified in their specialties, and together with our US trained full time Research Staff are well versed in the complexities of the conduction of trials, start up through completion.

Our Outpatient facility has been designed specifically for Phase IB through Phase IV Clinical Trials. We utilize the “All In House” Standard for our trials and utilize our facility as a central base with a Satellite Cardiac Catheterization Lab, soon to be completely incorporated into our In House Facility.

Facility Features:

PCRC Important Facts

• All Investigators are US Board Certified
• Highly Experienced Clinical Team with Complex Multiple trials
• Expertise in Numerous Medical Indications
• Trained Clinical Trial Staff
• Trial Specific Source Document Development
• “All in House” SOPs
• Approval by Central US IRB
• Rapid Turnaround of regulatory Documents
• Dual Collaboration of Local Ethics Board with Central IRB
• Large pool of Historically under Represented Ethnic Population
• English Speaking Population
• Experience in eCRF Data Capture and Management
• Experience in Transmission of Data
• Knowledge of IATA Shipment Requirements to Central Laboratories
• Experience in PK studies
• Optimal Study Subject Retention
• Minimal to Nil Advertising Required for Recruitment of Subjects

 Therapeutic Research Areas

• Women’s Health
• Cardiology
• Oncology
• Internal Medicine
• Vascular Diseases
• Endocrinology
• Nephrology/Urology
• Gastroenterology
• Immunology
• Infectious Disease
• Pharmacology/Toxicology

Specializing In:

• Phases I-IV Clinical Trials;
• First-In-Man Drug, Device and Biologics Clinical Trials;
• FDA Rigour in a Non-FDA Jurisdiction